Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies.
D000888:Antibodies, Anti-Idiotypic; D000917:Antibody Formation / Q000187:drug effects*; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D007106:Immune Sera; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D008722:Methods; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D007106:Immune Sera; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D012293:Rifampin